SCHEMBL20060102

SCHEMBL20060102

CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(N[SH](=O)=O)cc1)c1nc(C(C)(C)C)cs1

nearest known ligand 0.77

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 20/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19775217 0.91 PTPRB (0.78) PTPRB
SCHEMBL19775544 0.88 PTPRB (0.77) PTPRB
SCHEMBL468131 0.87 PTPRB (1.00) PTPRB
SCHEMBL3937502 0.87 PTPRB (1.00) PTPRB
SCHEMBL679344 0.87 PTPRB (1.00) PTPRB
SCHEMBL19775508 0.87 PTPRB (0.77) PTPRB
SCHEMBL12943873 0.85 PTPRB (0.87) PTPRB
SCHEMBL20060126 0.83 PTPRB (0.78) PTPRB
SCHEMBL19775193 0.80 PTPRB (0.75) PTPRB
SCHEMBL19775525 0.80 PTPRB (0.77) PTPRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3352856-B1 ACTIVATORS OF TIE-2 FOR USE IN TREATING INTRAOCULAR PRESSURE AERPIO PHARMACEUTICALS INC (US) 2021-08-18 EP disclosed
EP-3607821-A1 COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES Aerpio Therapeutics, Inc. (US) 2020-02-12 EP disclosed
EP-2385763-B1 METHODS FOR TREATING VASCULAR LEAK SYNDROME AERPIO THERAPEUTICS INC (US) 2018-04-18 EP disclosed